nicotine has been researched along with quercetin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Menon, VP; Muthukumaran, S; Nalini, N; Sudheer, AR | 2 |
| Chang, CH; Chang, HW; Chen, CS; Chen, FC; Ho, CT; Ho, YS; Hsu, CH; Liu, HC; Pan, MH; Shih, YL; Yang, YY | 1 |
| Clouse, J; Cugliari, MK; Jeffers, C; Mercado, J; Miao, J; Mullin, JM; Papanikolaou, E; Sedlak, J; Valenzano, MC; Wertan, NE | 1 |
| Crnjar, R; Solari, P; Sollai, G; Tomassini Barbarossa, I | 1 |
| Matić, MM; Ognjanović, BI; Paunović, MG; Saičić, ZS; Štajn, AŠ | 1 |
| Bolouki, A; Yarahmadi, A; Zal, F | 1 |
| Ardianto, C; Lailis, SR; Rahmadi, M; Ratri, DMN; Suasana, D | 1 |
| Eleftheriou, C; Zacharia, LC | 1 |
| Alsharairi, NA | 1 |
1 review(s) available for nicotine and quercetin
| Article | Year |
|---|---|
Quercetin Derivatives as Potential Therapeutic Agents: An Updated Perspective on the Treatment of Nicotine-Induced Non-Small Cell Lung Cancer.
Topics: Anthocyanins; Carcinoma, Non-Small-Cell Lung; Flavonoids; Humans; Lung Neoplasms; Nicotine; Quercetin | 2023 |
15 other study(ies) available for nicotine and quercetin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Protective effect of quercetin on nicotine-induced prooxidant and antioxidant imbalance and DNA damage in Wistar rats.
Topics: Acetylcysteine; Alkaline Phosphatase; Animals; Antioxidants; Body Weight; DNA Damage; Kidney; L-Lactate Dehydrogenase; Liver; Lung; Male; Nicotine; Oxidants; Quercetin; Rats; Rats, Wistar | 2008 |
Effect of quercetin on nicotine-induced biochemical changes and DNA damage in rat peripheral blood lymphocytes.
Topics: Acetylcysteine; Animals; Catalase; Cells, Cultured; Comet Assay; DNA Damage; Glutathione Peroxidase; Lipid Peroxidation; Lymphocytes; Male; Micronucleus Tests; Nicotine; Quercetin; Rats; Rats, Wistar; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 2008 |
Combination treatment with luteolin and quercetin enhances antiproliferative effects in nicotine-treated MDA-MB-231 cells by down-regulating nicotinic acetylcholine receptors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Luteolin; Nicotine; Protein Isoforms; Quercetin; Receptors, Nicotinic | 2010 |
Enhancement of tight junctional barrier function by micronutrients: compound-specific effects on permeability and claudin composition.
Topics: Animals; Biological Transport; Butyrates; Cell Line; Cell Membrane Permeability; Claudins; Electric Impedance; Epithelium; Indoles; Mannitol; Micronutrients; Nicotine; Quercetin; Sus scrofa; Tight Junction Proteins; Tight Junctions; Zinc | 2013 |
Taste discriminating capability to different bitter compounds by the larval styloconic sensilla in the insect herbivore Papilio hospiton (Géné).
Topics: Action Potentials; Animals; Benzyl Alcohols; Butterflies; Caffeine; Discrimination, Psychological; Feeding Behavior; Food Preferences; Glucosides; Herbivory; Larva; Neurons; Nicotine; Quercetin; Receptors, Cell Surface; Sensilla; Taste | 2015 |
Protective effects of quercetin and vitamin C against nicotine-induced toxicity in the blood of Wistar rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Male; Nicotine; Oxidative Stress; Protective Agents; Quercetin; Rats; Rats, Wistar | 2016 |
Protective effects of quercetin on nicotine induced oxidative stress in 'HepG2 cells'.
Topics: Drug Interactions; Hep G2 Cells; Humans; Nicotine; Oxidative Stress; Quercetin | 2017 |
The effects of quercetin on nicotine-induced reward effects in mice.
Topics: Animals; Conditioning, Psychological; Male; Mice; Nicotine; Quercetin; Reward; Tobacco Use Disorder | 2021 |
Topics: Animals; Dietary Supplements; Flavonoids; Ginkgo biloba; Mice; Microsomes, Liver; Nicotine; Quercetin; Smoking Cessation; Tobacco Use Cessation Devices | 2022 |